Sep 03,2019

Senseonics Announces Two Positive Blue Cross Blue Shield Coverage Decisions for Eversense CGM

Senseonics Holdings, Inc. a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Idaho are now providing coverage for Eversense CGM. These recent coverage decisions add to the growing number of payers who are writing Eversense into their CGM coverage policies, as well as paying for the healthcare provider’s time for the in-office sensor placement.

COLLABORATION COLLABORATION

#insurance

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 09,2019

DIAMONTECH SUCCESSFULLY COMPLETES A FINANCING ROUND OF OVER 7 MILLION EUROS

DiaMonTech GmbH, a young, innovative medical technology company, has successfully completed its Series A financing round. The company will receive a total of more than 7 million euros. The lead investor for this growth financing is Bioventure, an investor specializing in biotech and life sciences. In addition, DiaMonTech has gained two family offices as new investors. Existing shareholders - such as IBB Beteiligungsgesellschaft with the VC Fonds Technologie Berlin - also participated in the financing round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Sep 09,2019

Medtronic Announces Reimbursement in Germany for MiniMed™ 670G Insulin Pump System for Individuals with Type 1 Diabetes

Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it has secured reimbursement for the MiniMed™ 670G insulin pump system with the German Federal Association of the Statutory Health Insurances (GKV-SV).

PRODUCT

#insulin pump

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 09,2019

Dexcom G6® CGM System Now Available In Canada

"We are thrilled to offer the Dexcom G6 Continuous Glucose Monitoring (CGM) System to Canadians and are proud of this innovative technology that enables more effective diabetes management," said Laura Endres, Vice President and General Manager, Dexcom Canada, Inc. "The Dexcom G6 not only frees people with diabetes from the burden of fingersticks, but also offers real-time alerts and other features that can help people make more informed decisions for their daily diabetes management. This product changes people's lives."

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 09,2019

Virta Health’s Type 2 Diabetes Reversal Treatment Now Available to Blue Shield of California Members

Virta is thrilled to bring its treatment for type 2 diabetes reversal to eligible Blue Shield of California members. Virta is available through the nonprofit health plan’s newly re-launched Wellvolution digital therapeutics and community health network, which was developed by Solera Health.

COLLABORATION PARTNERSHIP

#insurance

View Analyst & Ambassador Comments
Go to original news
Sep 13,2019

ABBOTT'S REVOLUTIONARY FREESTYLE® LIBRE SYSTEM NOW REIMBURSED IN THE TWO LARGEST PROVINCES IN CANADA

Abbott (NYSE: ABT), the global leader in sensor-based glucose monitoring, announced today that it has received public reimbursement in Ontario and Quebec for its FreeStyle® Libre system, becoming the first sensor-based glucose monitoring system to be listed by any provincial health plan in Canada. Quebec residents 18 years or older2 and Ontario residents using insulin are eligible for reimbursement under the public programs. With its proven accuracy and ease of use,3 the FreeStyle Libre system replaces traditional blood glucose monitoring and allows patients to dose insulin based on the results.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 16,2019

ABBOTT AND SANOFI PARTNER TO INTEGRATE GLUCOSE SENSING AND INSULIN DELIVERY TECHNOLOGIES TO HELP CHANGE THE WAY DIABETES IS MANAGED

Abbott (NYSE: ABT) and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The two companies will take an innovative approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with Sanofi′s insulin dosing information for future smart pens, insulin titration apps and cloud software.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Sep 16,2019

Roche accelerates growth of its open ecosystem: Connecting the dots in integrated Personalised Diabetes Management to improve outcomes and bring true relief

A recent online survey of more than 600 people with diabetes has shown that the majority of the participants (91%) would be open to use digital diabetes management solutions. 81% of the respondents expected digital tools to enable a better overview of diabetes data. 52% of those surveyed also hoped that digital tools will provide more security and support in critical situations in order to react correctly when glucose levels are too high or too low. Managing diabetes is an everyday challenge and requires disciplined self-management and constant attention to therapy relevant information and data. Integrated personalised diabetes management has the potential to ease this burden by seamlessly combining innovative glucose monitoring devices, insulin delivery and digital health solutions with a structured therapy management approach.

View Analyst & Ambassador Comments
Go to original news
Sep 16,2019

Medtronic and Novo Nordisk Enter Agreement to Provide Integrated Digital Solutions for People with Diabetes

Medtronic plc, and Novo Nordisk A/S today announced a collaboration that will develop solutions to integrate insulin dosing data from future Novo Nordisk smart insulin pens into Continuous Glucose Monitoring (CGM) devices from Medtronic, such as the Guardian™ Connect system.

COLLABORATION PARTNERSHIP

#connected device

#insulin pen

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 16,2019

DIAMONTECH: INNOVATIVE, PAINLESS BLOOD SUGAR MEASUREMENT IS INTENDED TO IMPROVE THE QUALITY OF LIFE OF DIABETICS IN GERMANY WITH THE HELP OF LOCAL PHARMACIES

Germany's pharmacists want to make life easier for millions of diabetics by offering them a painless blood sugar measurement without taking blood as soon as possible. The German Association of Pharmacists e. V. (DAV) and DiaMonTech GmbH, a young, innovative medical technology company, intend to strategically work together to significantly improve the care of diabetics and take an innovative step into the future.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES